Antigen recognition MHC structure, function and antigen presentation Inactivation of Plasminogen Activator Inhibitor Type 1 by Neutrophil Bestase: the Evaluation of Its Physiologic Relevance in Rbdnolysis, Blood 1995, 86:1056-1061. Xia Y, Dawson VL, Dawson TM, Snyder SH, Zweier JL: Nitric Oxide Synthase Generates Superoxide and Nitric Oxide in Arglntne-deplated Cells Leading to Peroxynitrite-medlated Cellular Injury. Proc Nat/ Acad Sci USA 1996, 93:6770-6774. Yamada 1", Liepnieks J, Benson MD, Kluvebeckerman B: Accelerated Amylold Deposition in Mice Treated with the Aspartic Protesse Inhibitor, Pepstatin. J Immuno/1996, 157:901-907. Yanofsky SD, Baldwin DN, Butler JH, Holden FR, .lacobs JW, Balssubramanian P, Chinn JP, Cwirla SE, Petersbhatt E, Whitehorn EA, Tate EH, Akeson A, Bowfin TL, Dower WJ, Barrett RW: High Affinity Type I Interleukin 1 Receptor Antagonists Discovered by Screening Recombinant Peptide Libraries. Proc Nat/ Acad Sci USA 1996, 93:7381-7386. Yuan YP, Jackson SP, Newnham HH, Mitchell CA, Salem HH: An Essential Role for Lysophosphstidylcholine in the Inhibition of Platelat Aggregation by Secretory Phospholipase A(2). Blood 1995, 86:4166-4174. Yunis JJ, Corzo D, Salazar M, Lieberman JA, Howard A, Yunis EJ: HLA Associations in Clozapine-induced AgrenuIocytosis. Blood 1995, 86:1177-1183. Zondag GCM, Konlngstein GM, Jiang YP, Sap J, Moolanaar WH, Gebbink FBG: Hemophilic Interactions
/lp/elsevier/antigen-recognition-94rQHxELln